TIEMANN INVESTMENT ADVISORS, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1575151 MENLO PARK, CA

Position in GILD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$268,093

-$38,102 QoQ

Shares Held

2,122

-3.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#1,733

of 2,266 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TIEMANN INVESTMENT ADVISORS, LLC holds $9,289,456 across 7 Drug Manufacturers - General names. GILD ranks #6 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	10,451	$2,654,240
2	LLY	ELI LILLY & Co	2,149	$2,577,575
3	ABBV	AbbVie Inc.	9,227	$2,321,882
4	MRK	Merck & Co., Inc.	6,492	$834,222
5	AMGN	Amgen Inc	1,119	$405,212
6	GILD	Gilead Sciences, Inc. This page	2,122	$268,093
7	BMY	Bristol Myers Squibb Co	3,961	$228,232

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$268,093	2,122	-3.4%	Shares	Sole	2026-08-07
2026-03-31	$306,195	2,197	-4.4%	Shares	Sole	2026-05-13
2025-12-31	$281,933	2,297	0.0%	Shares	Sole	2026-02-13
2025-09-30	$254,967	2,297	0.0%	Shares	Sole	2025-11-13
2025-06-30	$254,668	2,297	-4.4%	Shares	Sole	2025-08-08
2025-03-31	$269,144	2,402	-3.0%	Shares	Sole	2025-05-14
2023-12-31	$200,661	2,477	+2.7%	Shares	Sole	2024-02-14
2023-06-30	$185,892	2,412	+1.3%	Shares	Sole	2023-08-11
2023-03-31	$197,634	2,382	+2.4%	Shares	Sole	2023-05-11
2022-12-31	$199,772	2,327	-29.0%	Shares	Sole	2023-02-14
2021-12-31	$237,942	3,277	+1.1%	Shares	Sole	2022-02-14
2021-03-31	$209,530	3,242	+1.0%	Shares	Sole	2021-05-12
2020-12-31	$187,014	3,210	-2.4%	Shares	Sole	2021-02-16
2020-09-30	$207,895	3,290	-13.8%	Shares	Sole	2020-11-12
2020-06-30	$293,526	3,815	+16.1%	Shares	Sole	2020-08-13
2020-03-31	$245,586	3,285	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.